Insmed (INSM) Amortization of Deferred Charges (2012 - 2026)

Insmed has reported Amortization of Deferred Charges for 15 years, with the latest figure at $1.4 million in Q2 2026.

• On a quarterly basis, Amortization of Deferred Charges fell 14.74% year-over-year to $1.4 million in Q2 2026; TTM through Jun 2026 was $5.5 million, a 17.86% decrease from a year earlier, with the FY2025 full-year figure at $6.2 million, down 9.7% from the prior year.
• Amortization of Deferred Charges was $1.4 million for Q2 2026 at Insmed, up from $1.4 million in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $2.0 million in Q2 2023, with the low at $821000.0 in Q2 2022.
• Average Amortization of Deferred Charges over 5 years is $1.5 million, with a median of $1.6 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Amortization of Deferred Charges plunged 84.36% in 2022, then jumped 144.09% in 2023.
• Over 5 years, Amortization of Deferred Charges stood at $1.5 million in 2022, then gained by 14.81% to $1.8 million in 2023, then decreased by 0.23% to $1.7 million in 2024, then declined by 21.28% to $1.4 million in 2025, then rose by 3.85% to $1.4 million in 2026.
• The last three Amortization of Deferred Charges figures came in at $1.4 million (Q2 2026), $1.4 million (Q1 2026), and $1.4 million (Q4 2025), per Business Quant data.